Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2012
05/17/2012US20120124705 Novel fatty acid desaturases and elongases and uses thereof
05/17/2012US20120124702 Plants Having Enhanced Yield-Related Traits And A Method For Making The Same
05/17/2012US20120124701 Promoter, promoter control elements, and combinations, and use thereof
05/17/2012US20120124700 Maize Ethylene Signaling Genes and Modulation of Same for Improved Stress Tolerance in Plants
05/17/2012US20120124699 Plant Defense Genes and Proteins and Methods of Use
05/17/2012US20120124698 Herbicide-tolerant plants through bypassing metabolic pathway
05/17/2012US20120124697 Plants with altered root architecture, related constructs and methods involving genes encoding nucleoside diphosphatase kinase (ndk) polypeptides and homologs thereof
05/17/2012US20120124696 method of gene introduction into triticum plant using agrobacterium, and a method of producing transformed triticum plant
05/17/2012US20120124686 Site-Directed Integration of Transgenes in Mammals
05/17/2012US20120124685 Compositions and methods for gene expression and chromatin profiling of individual cell types within a tissue
05/17/2012US20120124684 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury
05/17/2012US20120124683 Delivery method
05/17/2012US20120124682 Dhx36 / rhau knockout mice as experimental models of muscular dystrophy
05/17/2012US20120124681 Dna fragment and pharmaceutical composition
05/17/2012US20120123186 Therapeutic regimen for treating cancer
05/17/2012US20120123093 Novel surface antigen
05/17/2012US20120123090 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof
05/17/2012US20120123026 Functionalized compositions for improved immobilization
05/17/2012US20120122963 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122962 Modified Small Interfering RNA Molecules and Methods of Use
05/17/2012US20120122961 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
05/17/2012US20120122946 Polymorphisms for predicting disease and treatment outcome
05/17/2012US20120122796 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient
05/17/2012US20120122795 Accelerated extension of axons
05/17/2012US20120122778 Modified TGF-beta superfamily protein
05/17/2012US20120122771 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/17/2012US20120122770 Cell Cycle Arrest and Apoptosis
05/17/2012US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death
05/17/2012US20120122762 186 Human Secreted Proteins
05/17/2012US20120122718 BRM Expression and Related Diagnostics
05/17/2012US20120122716 Cell line derived from the epithelial lining of the human endolymphatic sac in the inner ear
05/17/2012US20120122699 Methods and Oligonucleotide Designs for Insertion of Multiple Adaptors Employing Selective Methylation
05/17/2012US20120122686 Novel glyphosate-n-acetyltransferase (gat) genes
05/17/2012US20120122225 Carrier peptide fragment and use thereof
05/17/2012US20120122217 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
05/17/2012US20120122216 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
05/17/2012US20120122206 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
05/17/2012US20120122205 Modular dna-binding domains and methods of use
05/17/2012US20120122204 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122203 METHODS AND KITS TO GENERATE miRNA- AND SMALL RNA-EXPRESSING VECTORS, AND ITS APPLICATION TO DEVELOP LENTIVIRAL EXPRESSION LIBRARIES
05/17/2012US20120122191 Methods For Producing Secreted Polypeptides
05/17/2012US20120122184 Polypeptides of strain Bacillus sp. P203
05/17/2012US20120122182 Gaussia luciferase variant for high-throughput screening
05/17/2012US20120122181 Method for determining antagonist activity to a cytokinin receptor
05/17/2012US20120122178 Human Aminoacyl-tRNA Synthetase Polypeptides Useful for the Regulation of Angiogenesis
05/17/2012US20120122169 Mutant yqhd enzyme for the production of a biochemical by fermentation
05/17/2012US20120122157 Signal Peptide for Producing a Polypeptide
05/17/2012US20120122156 Recombinant protein of fibroblast growth factor having adhesive activity for stem cells and method for culturing stem cells using the same
05/17/2012US20120122130 Coenzyme-Linked Glucose Dehydrogenase and Polynucleotide Encoding the Same
05/17/2012US20120122125 Anti-t. cruzi antibodies and methods of use
05/17/2012US20120122124 New bacteriophage adhesion proteins
05/17/2012US20120122120 Antibodies against human epo receptor
05/17/2012US20120122115 Bacterial quorum sensing biosensor
05/17/2012US20120122111 Rna sequence-specific mediators of rna interference
05/17/2012US20120122109 Neural progenitor cells derived from embryonic stem cells
05/17/2012US20120122107 Homeostatic multidomain protein, and uses for it
05/17/2012US20120122083 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
05/17/2012US20120121715 DNA Vaccine Comprising IL-6-Encoding DNA Construct and Applications Thereof
05/17/2012US20120121650 Chimeric Virus Vaccines
05/17/2012US20120121648 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
05/17/2012US20120121643 Engineered listeria and methods of use thereof
05/17/2012US20120121637 Chimeric factor h binding proteins (fhbp) and methods of use
05/17/2012US20120121635 Expression in plants of HIV-related proteins
05/17/2012US20120121631 Polyvalent vaccine
05/17/2012US20120121630 Recombinant ectodomain expression of herpes simplex virus glycoproteins in yeast
05/17/2012US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof
05/17/2012US20120121617 Promoters for recombinant viral expression
05/17/2012US20120121614 Methods and compositions for bi-specific targeting of cd19/cd22
05/17/2012US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121596 Bispecific anti-her antibodies
05/17/2012US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
05/17/2012US20120121589 Modified egfr ectodomain
05/17/2012US20120121585 SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121583 Antibodies against human tweak and uses thereof
05/17/2012US20120121575 Prohibitin as target for cancer therapy
05/17/2012US20120121568 Superoxide dismutase variants and methods of use thereof
05/17/2012US20120121551 Compositions and methods for immunostimulatory rna oligonucleotides
05/17/2012US20120121542 Red-shifted opsin molecules and uses thereof
05/17/2012US20120121538 Combined measles-malaria vaccine
05/17/2012US20120121537 Methods and Compositions for Inhibiting Hepatitis C Virus Replication
05/17/2012US20120121512 Monoclonal antibodies and their use
05/17/2012US20120121505 Therapeutic compositions and methods
05/17/2012US20120118308 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
05/17/2012US20120117933 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
05/17/2012US20120117868 Sugarcane Centromere Sequences And Minichromosomes
05/17/2012US20120117867 Plants with Increased Yield
05/17/2012CA2770750A1 High yielding soybean variety xb26x12
05/17/2012CA2770726A1 High yielding soybean variety xb31n12
05/17/2012CA2770601A1 High yielding soybean variety xr29d12
05/17/2012CA2770599A1 High yielding soybean variety xb17q12
05/17/2012CA2770598A1 High yielding soybean variety xb29p12
05/16/2012EP2453219A1 Nucleic acid extraction kit, nucleic acid extraction method, and nucleic acid extraction apparatus
05/16/2012EP2453018A1 A herbicide metabolizing protein, a gene thereof and use thereof
05/16/2012EP2453017A1 Oligonucleotides for use in prophylaxis and/or treatment of TGF-beta1 and TGF-beta2, TGF-beta2 and TGF-beta3, TGF-beta1 and TGF-beta3, or TGF-beta1, TGF-beta2, and TGF-beta3 mRNA overexpressing diseases
05/16/2012EP2453016A1 Methods for treating hypercholesterolemia
05/16/2012EP2453015A1 Identification marker responsive to interferon therapy for renal cell cancer
05/16/2012EP2453014A1 Treatment of cellulosic material and enzymes useful therein
05/16/2012EP2453013A1 Treatment of cellulosic material and enzymes useful therein
1 ... 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 ... 4023